Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001104659-08-022541
Filing Date
2008-04-04
Accepted
2008-04-04 11:09:49
Documents
3
Period of Report
2007-12-31

Document Format Files

Seq Description Document Type Size
1 10-K/A a08-10007_110ka.htm 10-K/A 100757
2 EX-31.1 a08-10007_1ex31d1.htm EX-31.1 6175
3 EX-31.2 a08-10007_1ex31d2.htm EX-31.2 6219
  Complete submission text file 0001104659-08-022541.txt   114699
Mailing Address 3 BETHESDA METRO CENTER SUITE 700 BETHESDA MD 20814
Business Address 3 BETHESDA METRO CENTER SUITE 700 BETHESDA MD 20814 3019611992
REGENERX BIOPHARMACEUTICALS INC (Filer) CIK: 0000707511 (see all company filings)

EIN.: 521253406 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-15070 | Film No.: 08739478
SIC: 2834 Pharmaceutical Preparations